ACXP - CIK 0001736243
The table below shows Acurx Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| $6.16M |
| $4.81M |
| $5.98M |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $9.54M | $6.11M | - | - | - | $6.58M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $2.53M | $2.47M | $2.59M | $2.49M | $3.32M | $3.15M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $2.53M | $2.47M | $2.59M | $2.49M | $3.32M | $3.15M |
| Retained earnings | -$76.97M | -$73.71M | -$71.72M | -$69.47M | -$64.54M | -$61.72M |
| Total equity | $7.01M | $3.64M | $3.57M | $2.31M | $2.66M | $3.43M |